Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Opicapone Improved Parkinson’s Disease-related Sleep Disturbances: Findings from the OASIS Study

Author:Gago, Miguel   Costa, Raquel   Fonseca, Miguel   Almeida, Joana   Brigas, Helena   Banisadr, Ghazal   Rocha, José-Francisco   Holenz, Joerg   Ferreira, Joaquim   

Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

Topic:Movement Disorders  

Program Number:P11.020  

Author Institution:Department of Neurology, ULS Alto Ave, Hospital da Senhora da Oliveira  Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho  CNS - Campus Neurológico, Guimarães, Portugal  BIAL – Portela & Ca S.A., CORONADO (S. Romão E S. Mamede, Portugal  Amneal Pharmaceuticals, Evanston, IL  IMM Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa  CNS-Campus Neurológico, Instituto De Medicin, Portugal  

Risk of Dementia in Patients with Benign Prostatic Hyperplasia: A Meta-analysis Comparing Tamsulosin with PGK1 Agonists, 5-ARI, and Other a-Blockers

Author:Ferreira da Silva, Alice Rayane   Aguiar, Rafael   Araújo, Gabriel   Campelo, Antônia   Linhares, ?Lucas   Benevides, ?Layla   Rego, Luis   Pinheiro, ?Bianca   Pinheiro, Samuel   Carvalho, ?Pedro   Menegaz de Almeida, Artur   

Session Name:P11: Aging, Dementia, and Behavioral Neurology: Co-morbidities, Complications, and Case Reports of Behavioral Neurology  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P11.020  

Author Institution:Federal University of Mato Grosso, Sinop, Brazil  

Attitudes and Beliefs in Parkinson’s Disease (PD) Research Participation

Author:Nanda Kumar, Prisha   Meng, Cheryl   Korell, Monica   Valdeverde Twiggs, Julien   Brown, Ethan   Comyns, Kathleen   Xuejie Chen, Sue   Clark, Adrienne   Tanner, Caroline   

Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

Topic:Movement Disorders  

Program Number:P11.021  

Author Institution:Philadelphia College of Osteopathic Medicine, Suwanee, GA  University of California San Francisco, Chicago, IL  University of California, San Francisco, San Francisco, CA  UCSF, San Francisco, CA  University of California San Francisco, Weill Institute for Neurosciences, SAN FRANCISCO, CA  

Investigating the Female Protective Effect in ALS: Insights from an Italian Cohort

Author:Grassano, Maurizio   Palumbo, Francesca   Moglia, Cristina   Mora, Gabriele   Calvo, Andrea   Traynor, Bryan   Chio, Adriano   

Session Name:P11: Neuromuscular and Clinical Neurophysiology (EMG): ALS and Other Motor Neuron Disorders  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P11.021  

Author Institution:Dept. of Neuroscience, University of Turin, Torino, Italy  National Institute on Aging, Bethesda, MD  

A Noninterventional Study to Evaluate Real-world Feasibility, Compliance, and Satisfaction with Digital Health Technologies for Parkinson’s Disease

Author:Abid, Nauman   Stemple, Whitney   Komuravelli, Madhu Kumar   

Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

Topic:Movement Disorders  

Program Number:P11.022  

Author Institution:BlueRock Therapeutics LP, Cambridge, MA  BlueRock Therapeutics LP, San Marcos, CA